<DOC>
	<DOC>NCT00578045</DOC>
	<brief_summary>The researchers want to find out if subjects treated on this study will achieve long term bone marrow recovery (engraftment) and if their tumors will respond to this treatment.</brief_summary>
	<brief_title>UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<criteria>Patients with advanced hematological malignancies who have failed at least two lines of therapy. Karnofsky performance score &gt; 60, unless due to disease and then &gt; 50. Age &gt; 18 years. An expected survival of &gt; 3 months. Subjects must have signed an IRBapproved consent and been informed about the investigational nature of the study. Cord blood must have negative serology for HIV. Release of cord blood. The nucleated cell count of the CBU shall equal or exceed 1 x 107 per kg of recipient body weight. Liver function: total bilirubin &gt; 2x ULN or AST/ALT &gt; 3x ULN. Creatinine &gt; 3.0 mg/dL.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>